Stock Scorecard
Stock Summary for Zai Lab Ltd (ZLAB) - $20.88 as of 8/7/2026 8:39:40 AM EST
Total Score
11 out of 30
Safety Score
29 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ZLAB
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ZLAB
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ZLAB
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ZLAB
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ZLAB (29 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for ZLAB
Financial Details for ZLAB
Company Overview |
|
|---|---|
| Ticker | ZLAB |
| Company Name | Zai Lab Ltd |
| Country | N/A |
| Description | Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 8/6/2026 |
Stock Price History |
|
| Last Day Price | 20.88 |
| Price 4 Years Ago | 30.70 |
| Last Day Price Updated | 8/7/2026 8:39:40 AM EST |
| Last Day Volume | 1,316,573 |
| Average Daily Volume | 743,844 |
| 52-Week High | 39.64 |
| 52-Week Low | 15.96 |
| Last Price to 52 Week Low | 30.83% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 140.35 |
| Sector PE | 97.16 |
| 5-Year Average PE | -15.42 |
| Free Cash Flow Ratio | 3.62 |
| Industry Free Cash Flow Ratio | 33.49 |
| Sector Free Cash Flow Ratio | 44.62 |
| Current Ratio Most Recent Quarter | 2.40 |
| Total Cash Per Share | 5.77 |
| Book Value Per Share Most Recent Quarter | 5.96 |
| Price to Book Ratio | 3.13 |
| Industry Price to Book Ratio | 13.33 |
| Sector Price to Book Ratio | 37.71 |
| Price to Sales Ratio Twelve Trailing Months | 4.54 |
| Industry Price to Sales Ratio Twelve Trailing Months | 8.72 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.86 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 112,923,000 |
| Market Capitalization | 2,357,832,240 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 31.73% |
| Reported EPS 12 Trailing Months | -1.70 |
| Reported EPS Past Year | -0.46 |
| Reported EPS Prior Year | -1.61 |
| Net Income Twelve Trailing Months | -178,115,000 |
| Net Income Past Year | -175,537,000 |
| Net Income Prior Year | -257,103,000 |
| Quarterly Revenue Growth YOY | -6.50% |
| 5-Year Revenue Growth | 56.54% |
| Operating Margin Twelve Trailing Months | -69.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 651,316,000 |
| Total Cash Past Year | 679,573,000 |
| Total Cash Prior Year | 449,667,000 |
| Net Cash Position Most Recent Quarter | 651,316,000 |
| Net Cash Position Past Year | 679,573,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 715,500,000 |
| Total Stockholder Equity Prior Year | 840,898,000 |
| Total Stockholder Equity Most Recent Quarter | 661,981,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -129,228,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.14 |
| Free Cash Flow Past Year | -158,890,000 |
| Free Cash Flow Prior Year | -276,391,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.16 |
| MACD Signal | -0.01 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.76 |
| RSI | 50.24 |
| 50-Day SMA | 21.80 |
| 150-Day SMA | 24.45 |
| 200-Day SMA | 26.57 |
System |
|
| Modified | 8/4/2026 12:25:52 PM EST |